* Dynavax Technologies Corp DVAX.OQ reported a quarterly
adjusted loss of 19 cents per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 13 cents per share.
* Revenue fell 58.8% to $46.93 million from a year ago;
analysts
expected $38.59 million.
* Dynavax Technologies Corp's reported EPS for the quarter
was a
loss of 19 cents.
* The mean earnings estimate of analysts had risen by
about 32.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Dynavax Technologies Corp shares had risen by 7.2% this
quarter and lost 1.1% so far this year.
* The company reported a quarterly loss of $24.33 million.
* Wall Street's median 12-month price target for Dynavax
Technologies Corp is $25.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
2 at 10:06 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.13 -0.19 Missed
Dec. 31 2022 0.43 0.45 Beat
Sep. 30 2022 0.33 0.43 Beat
Jun. 30 2022 0.22 0.87 Beat